Is BELLUS Health Inc. (BLU) a Buy, Sell, or Hold?
NASDAQ : BLU
BELLUS Health Inc. — Institutional Ownership
$14.745 USD
$0.01 (0.03%)
- Volume
- 2.84M
- Average Volume
- 2.9M
- Market Capitalization
- $1.87B
- P/E Ratio
- -22.34
- Dividend Yield
- 0.00%
- Price Target
- $14.75
- Year High
- $14.76
- Year Low
- $6.38
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $22.42
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2023-03-30 | Capital LP | 6.58M | 5.20% |
| 2023-03-30 | Capital Master LP | 6.58M | 5.20% |
| 2023-02-13 | GOLDMAN SACHS & CO. LLC | 8.08M | 6.40% |
| 2023-02-13 | THE GOLDMAN SACHS GROUP, INC. | 8.08M | 6.40% |
| 2022-02-14 | Polar Capital Holdings Plc | 2.5M | 2.40% |
| 2022-02-14 | Polar Capital LLP | 2.5M | 2.40% |
| 2022-02-14 | Joseph Edelman | 7.65M | 7.40% |
| 2022-02-14 | 2. | 10.0 | 0.20% |
| 2022-02-14 | Roderick Wong | 5.97M | 5.80% |
| 2022-02-14 | Point72 Asset Management, L.P. | - | 4.00% |
| 2022-02-14 | Perceptive Advisors LLC | 7.65M | 7.40% |
| 2022-02-14 | Commodore Capital LP | 5.46M | 5.30% |
| 2022-02-14 | Perceptive Life Sciences Master Fund, Ltd. | 7.65M | 7.40% |
| 2022-02-14 | RTW Investments, LP | 5.97M | 5.80% |
| 2022-02-14 | 2. | 10.0 | 5.30% |
| 2022-02-14 | 2. | 10.0 | 0.20% |
| 2022-02-14 | 2. | 10.0 | 0.20% |
| 2022-02-14 | 2. | 10.0 | 5.10% |
| 2022-02-14 | Commodore Capital Master LP | 5.46M | 5.30% |
| 2022-02-14 | 2. | 10.0 | 5.10% |
| 2022-02-14 | 2. | 10.0 | 5.10% |
| 2022-02-11 | Artal International S.C.A. | 8.5M | 8.20% |
| 2022-02-11 | Integrated Core Strategies (US) LLC | 3.85M | 3.70% |
| 2022-02-11 | ICS Opportunities, Ltd. | 209.93K | 0.20% |
| 2022-02-11 | Millennium International Management LP | 209.93K | 0.20% |
| 2022-02-11 | Millennium Management LLC | 4.06M | 3.90% |
| 2022-02-11 | Millennium Group Management LLC | 4.06M | 3.90% |
| 2022-02-11 | Israel A. Englander | 4.06M | 3.90% |
| 2022-02-11 | Westend S.A. | 8.5M | 8.20% |
| 2022-02-11 | Artal International Management S.A. | 8.5M | 8.20% |
| 2022-02-11 | Artal Treasury Limited | 8.5M | 8.20% |
| 2022-02-11 | Invus Public Equities Advisors, LLC | 8.5M | 8.20% |
| 2022-02-11 | Invus Public Equities, L.P. | 8.5M | 8.20% |
| 2022-02-11 | Mr. Amaury Wittouck | 8.5M | 8.20% |
| 2022-02-11 | Stichting Administratiekantoor Westend | 8.5M | 8.20% |
| 2022-02-11 | Artal Group S.A. | 8.5M | 8.20% |
| 2021-12-27 | 2. | 10.0 | 5.30% |
| 2021-12-27 | 2. | 10.0 | 5.10% |
| 2021-12-27 | 2. | 10.0 | 0.30% |
| 2021-12-27 | 2. | 10.0 | 0.20% |
| 2021-12-27 | 2. | 10.0 | 5.10% |
| 2021-12-27 | 2. | 10.0 | 5.10% |
| 2021-12-27 | 2. | 10.0 | 0.30% |
| 2021-12-22 | Rajeev Shah | 10.23M | 9.90% |
| 2021-12-22 | RA Capital Healthcare Fund, L.P. | 10.23M | 9.90% |
| 2021-12-22 | RA Capital Management, L.P. | 10.23M | 9.90% |
| 2021-12-22 | Peter Kolchinsky | 10.23M | 9.90% |
| 2021-12-06 | Perceptive Life Sciences Master Fund, Ltd. | 4.74M | 6.10% |
| 2021-12-06 | Perceptive Advisors LLC | 4.74M | 6.10% |
| 2021-12-06 | Joseph Edelman | 4.74M | 6.10% |
| 2021-09-24 | Integrated Core Strategies (US) LLC | 3.98M | 5.10% |
| 2021-09-24 | Millennium Group Management LLC | 3.98M | 5.10% |
| 2021-09-24 | Millennium Management LLC | 3.98M | 5.10% |
| 2021-09-24 | Israel A. Englander | 3.98M | 5.10% |
| 2021-09-03 | OrbiMed Capital GP VII LLC | 2.95M | 3.80% |
| 2021-09-03 | OrbiMed Advisors LLC | 2.95M | 3.80% |
| 2021-02-16 | Point72 Asset Management, L.P. | 6.22M | 4.00% |
| 2021-02-16 | Point72 Capital Advisors, Inc. | 6.22M | 4.00% |
| 2021-02-16 | Cubist Systematic Strategies, LLC | 20058.0 | 4.00% |
| 2021-02-16 | Steven A. Cohen | 6.24M | 4.00% |
| 2021-02-16 | Polar Capital Holdings Plc | 3.5M | 4.47% |
| 2021-02-16 | Polar Capital LLP | 3.5M | 4.47% |
| 2021-02-16 | Artal Group S.A. | 4.75M | 6.10% |
| 2021-02-16 | Stichting Administratiekantoor Westend | 4.75M | 6.10% |
| 2021-02-16 | Mr. Amaury Wittouck | 4.75M | 6.10% |
| 2021-02-16 | Invus Public Equities, L.P. | 4.75M | 6.10% |
| 2021-02-12 | Roderick Wong | 5.19M | 6.62% |
| 2021-02-12 | RTW Master Fund, Ltd. | 3.63M | 4.63% |
| 2021-02-16 | Artal International Management S.A. | 4.75M | 6.10% |
| 2021-02-16 | Artal International S.C.A. | 4.75M | 6.10% |
| 2021-02-12 | RTW Investments, LP | 5.19M | 6.62% |
| 2021-02-16 | Invus Public Equities Advisors, LLC | 4.75M | 6.10% |
| 2021-02-16 | Artal Treasury Limited | 4.75M | 6.10% |
| 2021-02-16 | Westend S.A. | 4.75M | 6.10% |
| 2021-02-12 | des travailleurs du Québec (F.T.Q.) | 472.53K | 0.80% |
| 2021-02-08 | Abigail P. Johnson | - | 0.00% |
| 2021-02-08 | FMR LLC | - | 0.00% |
| 2020-12-04 | Mr. Pascal Minne | 4.2M | 5.40% |
| 2020-12-04 | Artal International S.C.A. | 4.2M | 5.40% |
| 2020-12-04 | Stichting Administratiekantoor Westend | 4.2M | 5.40% |
| 2020-12-04 | Westend S.A. | 4.2M | 5.40% |
| 2020-12-04 | Artal Group S.A. | 4.2M | 5.40% |
| 2020-12-04 | Artal International Management S.A. | 4.2M | 5.40% |
| 2020-12-04 | Invus Public Equities, L.P. | 4.2M | 5.40% |
| 2020-12-04 | Invus Public Equities Advisors, LLC | 4.2M | 5.40% |
| 2020-12-04 | Artal Treasury Limited | 4.2M | 5.40% |
| 2020-10-23 | Point72 Capital Advisors, Inc. | 6.2M | 4.00% |
| 2020-10-23 | Point72 Asset Management, L.P. | 6.2M | 4.00% |
| 2020-10-23 | Cubist Systematic Strategies, LLC | 20058.0 | 4.00% |
| 2020-10-23 | Steven A. Cohen | 6.22M | 4.00% |
| 2020-10-23 | OrbiMed Capital LLC | 1.18M | 1.60% |
| 2020-10-23 | OrbiMed Advisors LLC | 3.95M | 5.20% |
| 2020-10-23 | OrbiMed Capital GP VII LLC | 3.95M | 5.20% |
| 2020-06-11 | OrbiMed Advisors LLC | 3.95M | 6.60% |
| 2020-06-11 | OrbiMed Capital LLC | 1.18M | 2.00% |
| 2020-06-11 | OrbiMed Capital GP VII LLC | 3.95M | 6.60% |
| 2020-02-14 | RTW Master Fund, Ltd. | 3.53M | 6.37% |
| 2020-02-14 | Roderick Wong | 4.84M | 8.74% |
| 2020-02-14 | RTW Investments, LP | 4.84M | 8.74% |
| 2020-02-14 | Polar Capital LLP | 3.02M | 5.46% |
| 2020-02-11 | Québec (F.T.Q.) (hereinafter referred to as “Fonds”) | 3.26M | 5.90% |
| 2020-02-07 | FMR LLC | 4.15M | 7.50% |
| 2020-02-07 | Abigail P. Johnson | 4.15M | 7.50% |
| 2020-02-06 | Roberto Bellini | 5.96M | 10.60% |
| 2020-02-06 | Carlo Bellini | 4.56M | 8.20% |
| 2020-02-06 | Rocabe Investments Inc. | 4.56M | 8.20% |
| 2020-01-31 | Power Corporation of Canada | 4.94M | 8.90% |
| 2020-01-31 | Power Sustainable Capital Investments Inc. | 4.94M | 8.90% |
| 2019-09-18 | OrbiMed Advisors LLC | 4.94M | 8.90% |
| 2019-09-18 | OrbiMed Capital GP VII LLC | 4.94M | 8.90% |
| 2019-09-18 | OrbiMed Capital LLC | 2.08M | 3.70% |
| 2019-09-16 | RTW Master Fund, Ltd. | 2.77M | 5.12% |
| 2019-09-16 | RTW Investments, LP | 3.62M | 6.69% |
| 2019-09-16 | Roderick Wong | 3.62M | 6.69% |
| 2007-05-03 | Francesco Bellini | 825.93K | 2.10% |
| 2007-05-03 | H. Strang | 11.65M | 30.00% |
| 2007-05-03 | W. Churchill | 11.65M | 30.00% |
| 2007-05-03 | Family Trust | 11.65M | 30.00% |
| 2007-05-03 | Pharma Inc. | 11.4M | 29.40% |
| 2007-05-03 | Technology Investment Corporation | 12.57M | 32.40% |
| 2007-05-03 | P. Luxco Holdings II S.A.R.L. | 11.07M | 28.50% |
BLU Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2022-12-31 | $8.22 | 115.36M | $948.25M | $87.25M | $1.28M | $862.28M |
| 2021-12-31 | $8.05 | 79.32M | $638.49M | $150.08M | $871K | $489.29M |
| 2020-12-31 | $3.06 | 59.02M | $180.61M | $48.89M | $503K | $132.23M |
| 2019-12-31 | $9.86 | 53.41M | $526.72M | $18.58M | $186.79K | $508.33M |
| 2018-12-31 | $3.79 | 33.62M | $127.52M | $10.96M | -$ | $116.56M |
| 2017-12-31 | $1.41 | 19.07M | $26.86M | $6.16M | -$ | $20.69M |
| 2016-12-31 | $1.02 | 16.22M | $16.52M | $1.92M | -$ | $14.6M |
| 2015-12-31 | $3.69 | 13.17M | $48.66M | $2.19M | -$ | $46.47M |
| 2014-12-31 | $4.78 | 13.17M | $62.96M | $7.66M | -$ | $55.3M |
| 2013-12-31 | $1.50 | 13.17M | $19.73M | $10.59M | $4.87M | $14.01M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-09-30 | $14.74 | 392.95M | $5.79B | $228.64M | -$ | $5.56B |
| 2023-06-30 | $14.74 | 410.34M | $6.05B | $253M | -$ | $5.8B |
| 2023-03-31 | $7.20 | 126.58M | $911.39M | $85.38M | $1.2M | $827.21M |
| 2022-12-31 | $8.22 | 115.36M | $948.25M | $87.25M | $1.28M | $862.28M |
| 2022-09-30 | $10.56 | 121.8M | $1.29B | $72.86M | $603K | $1.21B |
| 2022-06-30 | $9.24 | 106.76M | $986.44M | $121.72M | $720K | $865.45M |
| 2022-03-31 | $6.88 | 106.49M | $732.65M | $147.16M | $845K | $586.34M |
| 2021-12-31 | $8.05 | 78.83M | $634.55M | $150.08M | $871K | $485.35M |
| 2021-09-30 | $6.14 | 78.34M | $480.99M | $25.28M | $394K | $456.11M |
| 2021-06-30 | $3.11 | 78.34M | $243.63M | $29.12M | $431K | $214.94M |
| 2021-03-31 | $3.84 | 78.34M | $300.82M | $32.46M | $484K | $268.84M |
| 2020-12-31 | $3.06 | 59.73M | $182.79M | $48.89M | $503K | $134.4M |